
We are Cambridge CARES, the University of Cambridge’s research centre in Singapore, established under the National Research Foundation (NRF) CREATE programme CAM.CREATE. Within Cambridge CARES, BloodCounts! is a collaborative research initiative bringing together A*STAR, Nanyang Technological University, National University of Singapore, National University Health System (NUHS) and SingHealth Hospitals, with the University of Cambridge and the company Sysmex, and many other partners in the UK, Belgium, The Gambia, Ghana, India, and the Netherlands.
BloodCounts! focusses on elevating the value of the complete blood count (known as full blood count in Singapore and the UK), the most common medical test globally, by developing new AI methodologies. In particular, we have access to population scale raw flow cytometry data that is used to generate the summary complete blood count report used by millions of healthcare workers on a daily basis. We have demonstrated that applying AI methods to this data allows for additional insights to be discovered, such as identifying markers for cancers, iron deficiency and causes of infection.
This National Research Foundation AI for Science (AI4S) supported BloodCounts! project will develop multi-modal foundation models of the blood using not only flow cytometry data but also cell imaging data. The foundation models will be developed using anonymised data from NUHS and SingHealth patients, with the aim of developing a population scale foundation model of blood that performs equitable for all ancestries in Singapore. The models developed will be applied to clinical studies for Stroke and Lung Cancer, with the aim to identify new markers that impact clinical treatment.
The BloodCounts!-AI4S project in Singapore will integrate into the wider BloodCounts! consortium, allowing for co-development of models and rapid testing of hypotheses in European, African, South Asian and East Asian populations. Researchers globally will be able to access our models and insights through a secure platform, APIs and open sourced code and models.
The BloodCounts! AI4S Team is led by Profs. Michael Roberts, Carola-Bibiane Schönlieb (Department of Applied Mathematics and Theoretical Physics (DAMTP), University of Cambridge, UK) and Lin Weisi (College of Computing & Data Science, Nanyang Technological University, Singapore). They are supported by Dr Nicholas Gleadall (University of Cambridge), Prof. Iain Bee Huat Tan (SingHealth), Prof. Hui Ji (NUS), Prof. Mickey Koh (St. George’s Hospital, London; ACTRIS, Singapore), Dr Hwee Kuan Lee (A*STAR), Prof. Parashkev Nachev (University College London Hospitals), Prof. Willem H Ouwehand (University of Cambridge), Dr Suthesh Sivapalaratnam (Barts Health, London) and Dr Chuen Wan Tan (SingHealth) alongside a wider group of collaborators.
The Lead Research Software Engineer will be responsible for the software and data infrastructure deliverables of the project, including the delivery of curated datasets for the clinical studies, all backend infrastructure and pipelines along with the deployment tools. They will work day-to-day with the Lead Machine Learning Researcher to deliver an ecosystem of tools required to perform rapid-iteration high-quality reproducible AI research within which all research will be performed. They will be the main point of contact for all queries around hardware and software.
Please note that this post is mainly based in the CREATE Tower at NUS University Town, Singapore.
The position is available for an immediate start and is offered on a fixed-term contract of two years in the first instance, with the possibility of extension.
To apply, please send your CV and cover letter (summarising the most relevant skills and experience that you have for the position).

Cambridge Enterprise is the commercialisation arm of the University of Cambridge.
At Cambridge Enterprise, we help University of Cambridge members create beneficial impact from their research and expertise that can change the world, through academic consultancy, intellectual property management, development and licensing, venture building, venture funding and convening and connecting the wider Cambridge innovation ecosystem.
Our success is measured in the success of our University partners as they bring their work to market, be it ground-breaking stem cell research, critical suspension technology used in Formula 1 racing, or a flower seed mix to enable bees to flourish and crops grow. We’re here to make the world a better place by helping to create a legacy of products, services and advice that benefit not just the University and the UK, but everyone.